Skip to content
Open access · CC-BY via OpenAlex

Restorin® NR is a Highly Efficient NAD+ Precursor

Brett Weiss, Rui Cao, Yongzheng Liu, Jiaqi Chen, George Marshall

Drug Design Development and Therapy · 2026

Abstract

Introduction: Nicotinamide adenine dinucleotide (NAD+) is vital for maintaining normal cellular function. Aging-associated NAD+ decline is linked to the onset and progression of age-related diseases. Consequently, oral supplementation of NAD+ precursors has been shown to improve disease-relevant phenotypes and physiological outcomes in model organisms. Among NAD+ precursors, nicotinamide riboside (NR) has attracted interest owing to its potent in vivo NAD+ biosynthetic activity. However, NR exhibits poor stability in the circulatory system. Thus, there is considerable interest in discovering effective NAD+ precursor forms that can address these limitations. Here, we report Restorin NR, a proprietary crystalline form of NR fumarate, as a novel NAD+ enhancer. Methods: The current study was performed to compare the effectiveness of three different NAD+ precursors, including nicotinamide mononucleotide (NMN), NR chloride, and Restorin NR in boosting NAD+ levels in an aged murine model. Results: The results showed that Restorin NR significantly increased NAD+ levels above equivalent doses of NMN or NR chloride. Notably, Restorin NR at the low dose of 0.33 mmol/kg/day induced blood NAD+ elevation statistically equivalent to that of a higher dose of NR chloride or NMN (1 mmol/kg/day, n=11). At the matched dose of 1 mmol/kg/day, Restorin NR yielded significantly higher circulating NAD+ levels than either comparison treatment. These results confirm Restorin NR's superiority to the tested precursors for NAD+ concentrations in circulation. Discussion: Overall, our research identifies a new crystalline salt form of NR and classifies Restorin NR as a promising new therapeutic agent to enhance NAD+ levels and combat aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.2147/dddt.s639156
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Weiss, B., Cao, R., Liu, Y., Chen, J., &amp; Marshall, G. (2026). Restorin® NR is a Highly Efficient NAD+ Precursor. <em>Drug Design Development and Therapy</em>. https://doi.org/10.2147/dddt.s639156
Vancouver
Weiss B, Cao R, Liu Y, Chen J, Marshall G. Restorin® NR is a Highly Efficient NAD+ Precursor. Drug Design Development and Therapy. 2026. doi:10.2147/dddt.s639156.
BibTeX
@article{brett2026Restor, title = {Restorin® NR is a Highly Efficient NAD+ Precursor}, author = {Brett Weiss and Rui Cao and Yongzheng Liu and Jiaqi Chen and George Marshall}, journal = {Drug Design Development and Therapy}, year = {2026}, doi = {10.2147/dddt.s639156}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings